The masterclass is designed for students and scientists who possess basic crystallographic knowledge and who would like to acquire practical skills for refining crystal structures based on single-crystal X-ray diffraction data. Both novice and experienced users will benefit from the course and will enhance their knowledge of mathematical foundations of diffraction principles, computer software, and crystal structure determination. The course will cover the concepts of crystallographic analysis including point/space group symmetry, the use of reciprocal lattice to understand diffraction by crystals, and crystallographic experiment design.

Andreas Deutsch, Professor of Technical University of Dresden, will hold a workshop "Mechanisms of cancer growth, invasion, and progression: a biomathematical modeling analysis".

Research of the department is directed at the development of innovative mathematical models and simulation tools to detect organizational principles of selected biological systems. Researchers focus on "cellular systems" which possess a multitude of interaction mechanisms whose cooperative interplay guarantees in particular the development of organismic forms. Disorders in cell interaction can lead to diseases and malignant pattern formation (e.g. tumor growth). Important insights into function and regulation of biological systems can be gained by linking mathematical modeling and computational tools with biological/medical in vitro, and in vivo data. The staff work on interdisciplinary projects on the basis of local, national, and international cooperation. They develop the software Morpheus, a modeling and simulation environment for the study of multiscale and multicellular systems.

Goal of the Conference:To reveal the diversity of functional aspects of intercultural communication within the process of world education integration, to focus on translation and interpreting issues in the conditions of the modern society.

He has been studying the language and the culture of the Trobriand Islanders of Papua New Guinea since 1982 and conducted field research on the Trobriand Islands for 45 months during 16 long- and short-term field-trips between 1982 and 2012.

Medium-sized nitrogen heterocycles (7-to-15-membered) have widespread interest in organic synthesis and medicinal chemistry.

As a result of joint researches, methods for the synthesis of mixed heterocyclic ligands containing heterocycles completely different in electronic properties (for example, 1,2-azole-1,2,3-triazole, 1,2-azole-pyridine, 1,2-azole-pyrimidine) and their complexes with palladium and nickel were obtained. Palladium isoxazole-1,2,3-triazole complexes are such active catalysts for cross-coupling and reduction reactions in aqueous media that they can be used in trace amounts (1–10 ppm). For the first time, a promising and very active in catalysis of cross-coupling and reduction reactions hybrid bimetallic material based on Pd-Ni-B-L doped with palladium and modified with azole ligands [L - isoxazole-1,2,3-triazole(pyrimide) ligands] was developed.

Topic: Connection of inequalities for a maximal operator in Morrey-type spaces and inequalities for a Hardy operator for monotonically decreasing functions.

Speaker: Malygina Vera V., candidate of physical and mathematical sciences, associate professor, leading researcher, Functional Differential Equations Research Center, Perm National Research Polytechnic University, Perm, Russia.

Speaker: Liiko Victoriia, PhD student of The Mathematical Institute of RUDN University.

Fragment-based drug design (FBDD) can be considered as the most successful structure-based drug design (SBDD) approach.

Main topics of the conference: Blow-up and singularities for nonlinear PDEs; Peaking regimes in nonlinear evolution equations; Large solutions of nonlinear elliptic and parabolic equations and systems;

Since the first protein structures were determined through X-ray crystallography in the early 1960s, the knowledge of the three-dimensional structure of therapeutically relevant targets has informed and usefully supported drug discovery.